Juvenile arthritis damage index predicts poor response to biological treatment: A prospective cohort study

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Clin Pediatr. Dec 9, 2025; 14(4): 108878
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.108878

Table 6 Predictors of articular damage improvement (multiple regression analysis data), n (%)

Predictor	Β	SE	P value
Intercept	-0.026	0.198	0.896
Treatment with nbDMARDs at the EOS	0.343	0.119	0.006
Stable bDMARD treatment during the study	0.249	0.119	0.042

EOS: End of study; bDMARD: Biologic disease-modified antirheumatic drugs; nbDMARDs: Non-biologic disease-modified antirheumatic drugs.

Citation: Kolkhidova ZA, Nikishina IP, Glukhova SI, Melikhov OG, Kostik MM. Juvenile arthritis damage index predicts poor response to biological treatment: A prospective cohort study. World J Clin Pediatr 2025; 14(4): 108878
URL: https://www.wjgnet.com/2219-2808/full/v14/i4/108878.htm
DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.108878

Kolkhidova ZA, Nikishina IP, Glukhova SI, Melikhov OG, Kostik MM. Juvenile arthritis damage index predicts poor response to biological treatment: A prospective cohort study. World J Clin Pediatr 2025; 14(4): 108878 [PMID: 41255656 DOI: 10.5409/wjcp.v14.i4.108878]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.